Daiichi Sankyo & AstraZeneca’s Enhertu receives 2024 Prix Galien USA Award for Best Biotechnology Product: Tokyo Monday, November 11, 2024, 09:00 Hrs [IST] Daiichi Sankyo and As ...

ALT-B4 is Alteogen's proprietary human recombinant hyaluronidase enzyme developed utilizing HybrozymeTM technology. ALT-B4 can enable the large volume subcutaneous administration of drugs that are ...

Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the ...

(MENAFN- Daily News Egypt) Bassel Rahmy, CEO of the Micro, Small and Medium Enterprise Development Agency (MSMEDA), ...

Viking's candidates, like Eli Lilly's, fall into the dual GLP-1/GIP category. The results of these commercialized treatments, ...

LG Display, the world's leading innovator of display technologies, announced today its unveiling of the world's first ...

Northern Argentina’s Campo del Cielo is where the world's largest mass of meteorites has been found. And it has also been ...

Noisy environments pose a challenge to deaf people, particularly when they're trying to discern what a specific person within ...

Binance Labs has invested in BIO Protocol, a pioneering protocol transforming the way early-stage scientific research is ...

BIOFRONT® resin aligns with Teijin Frontier’s THINK ECOⓇ environmental strategy and joins the company’s wide range of ...

Under outside pressure, the International Olympic Committee has turned into circus buffoonery, Russian President said ...